Bionow announce shortlist of nominees for the annual Bionow Awards

BIonow Awards 2022 logo.

The nominees for the annual Bionow Awards have been announced, with the prestigious event due to once again highlight the great work that the life sciences sector has to offer.

The awards ceremony celebrates the achievements of the sector, showcasing the very best in the industry, and taking place at the iconic Concorde Conference Centre. This year’s event promises to be no different in celebrating a wide range of innovative companies, as it was another great year for nominations, with two brand new categories for 2022.

The nominees were selected by a panel of judges, please click on each section to view each categories nominees: 

  • Rapid Fluidics
  • Spotlight Pathology
  • Viveca Biomed
  • F2G: Novel Therapy for Invasive Fungal Infections in Patients Lacking Options
  • Immundnz: Assay to assess susceptibility to cytokine storm in patients at risk
  • University of Manchester: Identifying new treatments for patients with rare cancers (DETERMINE trial)
  • Alchemab Therapeutics: Novel protective ‘self’-antibodies for disease modification in Huntington’s Disease
  • CPI: Soteria – Development of a Scalable Manufacturing Process for Oral Infliximab
  • University of Liverpool: MicroAge – Microgravity as a model for accelerated skeletal muscle ageing
  • Crest Solutions: CXV Global SmartFactory LineClearance AssistantTM
  • Tectores: PelliTec blister prevention pads
  • TRUPCR Europe: TRUPCR BCR-ABL1 Transcript Screening Kit
  • Agility Life Sciences: Fast Futureproof Formulations
  • Crystec: mSAS® – revolutionising the speed and efficiency of biomolecule product development
  • Rapid Fluidics: Next-day turnaround of rapid-prototype microfluidic devices
  • Medicines Discovery Catapult: Psychiatry Consortium
  • Sterling Pharma Solutions: Sterling Pharma Solutions/Northumbria University Biocatalysis Knowledge Transfer Partnerships
  • University of Manchester: Identifying new treatments for patients with rare cancers (DETERMINE trial)
  • Laura Ajram, Medicines Discovery Catapult
  • Michael Eyres, Medicines Discovery Catapult
  • John Forsey, Pharmaron Biologics (UK)
  • Kimberly Rockley, ApconiX
  • F2G: F2G and Shionogi collaborate to bring new antifungal to Europe
  • QV Bioelectronics: Pre-Series A
  • Daresbury Proteins: Investment from LYVA Labs, the Liverpool City Region’s innovation commercialisation organisation
  • Sai Life Sciences
  • Seda Pharmaceutical Development Services
  • Sterling Pharma Solutions
  • CSL Seqirus
  • FibroFind
  • Seda Pharmaceutical Development Services

Geoff Davison, CEO of Bionow said: “The quality of applications has been truly exceptional and it was so difficult to narrow it down. We were also very impressed by the entries for our two new categories, Partnership & Collaboration and Business Growth. We can’t wait to see everyone at the awards ceremony on 16th March.”

Back to top